DK461689A - Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri - Google Patents
Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri Download PDFInfo
- Publication number
- DK461689A DK461689A DK461689A DK461689A DK461689A DK 461689 A DK461689 A DK 461689A DK 461689 A DK461689 A DK 461689A DK 461689 A DK461689 A DK 461689A DK 461689 A DK461689 A DK 461689A
- Authority
- DK
- Denmark
- Prior art keywords
- active substances
- seritoninagonistic
- preparation
- application
- effect
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract 1
- 102000017911 HTR1A Human genes 0.000 abstract 1
- 101150015707 HTR1A gene Proteins 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Instructional Devices (AREA)
- Cephalosporin Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3831888 | 1988-09-20 | ||
| DE3831888A DE3831888A1 (de) | 1988-09-20 | 1988-09-20 | Arzneimittel zur behandlung von apoplexia cerebri |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK461689D0 DK461689D0 (da) | 1989-09-19 |
| DK461689A true DK461689A (da) | 1990-03-21 |
| DK175128B1 DK175128B1 (da) | 2004-06-07 |
Family
ID=6363313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK198904616A DK175128B1 (da) | 1988-09-20 | 1989-09-19 | Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af lægemidler med Apoplexia cerebri |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US4988700A (da) |
| EP (1) | EP0360077B1 (da) |
| JP (1) | JP2669507B2 (da) |
| KR (2) | KR0135307B1 (da) |
| AT (1) | ATE91623T1 (da) |
| AU (1) | AU619895B2 (da) |
| CA (1) | CA1331139C (da) |
| DE (2) | DE3831888A1 (da) |
| DK (1) | DK175128B1 (da) |
| ES (1) | ES2058426T3 (da) |
| FI (1) | FI894404A (da) |
| HU (1) | HU203475B (da) |
| IE (1) | IE62697B1 (da) |
| IL (1) | IL91660A (da) |
| PH (1) | PH26920A (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06504279A (ja) * | 1990-12-24 | 1994-05-19 | メレルダウファーマス−ティカルズ インコーポレイテッド | 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途 |
| DE4135473A1 (de) * | 1991-10-28 | 1993-04-29 | Bayer Ag | Triazaspirodecanon-methylchromane |
| DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
| EP0663014B1 (en) * | 1992-09-25 | 2004-08-18 | Synaptic Pharmaceutical Corporation | Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| WO1994009765A1 (en) * | 1992-10-23 | 1994-05-11 | New York University | Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| ATE255888T1 (de) | 1998-06-01 | 2003-12-15 | Ortho Mcneil Pharm Inc | Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| DE69919707T2 (de) | 1998-06-19 | 2005-09-01 | Chiron Corp., Emeryville | Glycogen synthase kinase 3 inhibitoren |
| EP1100794A1 (en) | 1998-07-17 | 2001-05-23 | Synaptic Pharmaceutical Corporation | COMPOUNDS SPECIFIC FOR THE HUMAN $g(a) 1d? ADRENERGIC RECEPTOR AND USES THEREOF |
| US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| DE19900544A1 (de) * | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
| US20040106623A1 (en) * | 1999-07-16 | 2004-06-03 | Synaptic Pharmaceutical Corporation | Compounds specific for the human alpha1d adrenergic receptor and uses thereof |
| US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
| US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| US20040002500A1 (en) * | 2002-06-28 | 2004-01-01 | Fabre Kramer Pharmaceutical, Inc. | Methods for treating attention deficit disorder |
| US20040077996A1 (en) * | 2002-10-22 | 2004-04-22 | Jasperson Keith E. | Drug infusion system with multiple medications |
| US7375219B2 (en) * | 2005-04-13 | 2008-05-20 | Neuraxon, Inc. | Substituted indole compounds having NOS inhibitory activity |
| TW200808780A (en) * | 2006-04-13 | 2008-02-16 | Neuraxon Inc | 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity |
| US20090131503A1 (en) * | 2007-11-16 | 2009-05-21 | Annedi Subhash C | 3,5 - substituted indole compounds having nos and norepinephrine reuptake inhibitory activity |
| WO2009064505A1 (en) * | 2007-11-16 | 2009-05-22 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods for treating visceral pain |
| BRPI0820632A2 (pt) * | 2007-11-16 | 2015-06-16 | Neuraxon Inc | Compostos de indol e métodos para tratamento de dor visceral |
| KR102357405B1 (ko) | 2021-05-07 | 2022-02-09 | 정진구 | 호흡기 운동기구 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8810748D0 (en) * | 1988-05-06 | 1988-06-08 | Beecham Wuelfing Gmbh & Co Kg | Novel treatment |
-
1988
- 1988-09-20 DE DE3831888A patent/DE3831888A1/de not_active Withdrawn
-
1989
- 1989-09-06 PH PH39203A patent/PH26920A/en unknown
- 1989-09-07 DE DE8989116496T patent/DE58904960D1/de not_active Expired - Fee Related
- 1989-09-07 AT AT89116496T patent/ATE91623T1/de not_active IP Right Cessation
- 1989-09-07 EP EP89116496A patent/EP0360077B1/de not_active Expired - Lifetime
- 1989-09-07 ES ES89116496T patent/ES2058426T3/es not_active Expired - Lifetime
- 1989-09-14 US US07/407,161 patent/US4988700A/en not_active Expired - Lifetime
- 1989-09-15 AU AU41456/89A patent/AU619895B2/en not_active Ceased
- 1989-09-15 IL IL91660A patent/IL91660A/xx not_active IP Right Cessation
- 1989-09-18 FI FI894404A patent/FI894404A/fi not_active Application Discontinuation
- 1989-09-18 CA CA000611736A patent/CA1331139C/en not_active Expired - Fee Related
- 1989-09-19 KR KR1019890013434A patent/KR0135307B1/ko not_active IP Right Cessation
- 1989-09-19 DK DK198904616A patent/DK175128B1/da not_active IP Right Cessation
- 1989-09-19 IE IE299089A patent/IE62697B1/en not_active IP Right Cessation
- 1989-09-20 HU HU894897A patent/HU203475B/hu not_active IP Right Cessation
- 1989-09-20 JP JP1242417A patent/JP2669507B2/ja not_active Expired - Fee Related
-
1990
- 1990-09-10 US US07/579,414 patent/US5070102A/en not_active Expired - Lifetime
-
1991
- 1991-06-13 US US07/714,470 patent/US5155128A/en not_active Expired - Lifetime
-
1997
- 1997-11-20 KR KR1019970061360A patent/KR0146486B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3831888A1 (de) | 1990-03-29 |
| ATE91623T1 (de) | 1993-08-15 |
| CA1331139C (en) | 1994-08-02 |
| HUT52699A (en) | 1990-08-28 |
| AU4145689A (en) | 1990-03-29 |
| EP0360077A2 (de) | 1990-03-28 |
| JP2669507B2 (ja) | 1997-10-29 |
| IL91660A (en) | 1993-08-18 |
| US5155128A (en) | 1992-10-13 |
| FI894404A0 (fi) | 1989-09-18 |
| IL91660A0 (da) | 1990-04-29 |
| AU619895B2 (en) | 1992-02-06 |
| US5070102A (en) | 1991-12-03 |
| HU203475B (en) | 1991-08-28 |
| EP0360077A3 (de) | 1992-03-11 |
| ES2058426T3 (es) | 1994-11-01 |
| DK175128B1 (da) | 2004-06-07 |
| KR0146486B1 (ko) | 1998-08-17 |
| IE62697B1 (en) | 1995-02-22 |
| PH26920A (en) | 1992-12-03 |
| JPH02121935A (ja) | 1990-05-09 |
| FI894404A (fi) | 1990-03-21 |
| US4988700A (en) | 1991-01-29 |
| KR0135307B1 (ko) | 1998-04-23 |
| DE58904960D1 (de) | 1993-08-26 |
| DK461689D0 (da) | 1989-09-19 |
| IE892990L (en) | 1990-03-20 |
| KR900004352A (ko) | 1990-04-12 |
| EP0360077B1 (de) | 1993-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK461689D0 (da) | Anvendelse af aktive stoffer med seritoninagonistisk virkning til fremstilling af laegemidler med apoplexia cerebri | |
| NO882560D0 (no) | Midler for aa oeke transdermal stroemning av farmasoeytiske stoffer. | |
| AR224243A1 (es) | Procedimiento para aumentar la viscosidad de preparados cosmeticos,farmaceuticos y tecnicos | |
| DE3879853D1 (de) | Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien. | |
| FR2649888B1 (fr) | Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques | |
| DK143588A (da) | Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler | |
| NL970023I1 (nl) | Medicamenten voor behandeling van oogontsteking. | |
| IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
| DK299089D0 (da) | Anvendelse af prostaglandiner til fremstilling af laegemidler | |
| DK522186A (da) | Melatoninmaterialer og deres anvendelser | |
| IT1193431B (it) | Procedimento per la preparazione di prodotti antispasmici da applicare alla pelle particolarmente contro gli spasmi muscolari | |
| MX15184A (es) | Procedimiento para la preparacion de derivados de isoindolinona,compuesto obtenido y medicamento quelo incluye. | |
| DK208784A (da) | Farmaceutisk produkt til kontrolleret afgivelse af aktive stoffer til huden | |
| ATE234082T1 (de) | Adenosin enthaltendes arzneimittel | |
| FR2537584B1 (fr) | Pyrazoloquinoleines substituees particulieres, procede pour leur preparation, preparations pharmaceutiques contenant ces composes et leur application therapeutique | |
| PT89478B (pt) | Processo para a preparacao de piridinas di-substituidas | |
| IT8519907A0 (it) | Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea. | |
| NO179632C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat som inneholder podofyllotoksin | |
| DE3583234D1 (de) | Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln. | |
| IT1093702B (it) | 2,4-diclorofenti-imidazolil-etanoni (oli),procedimento per la loro preparazione e loro impiego come prodotti medicinali | |
| BE873259A (fr) | Acides acylhydrocarbylaminoalkancarboxyliques leur preparation et leur utilisation, ainsi que medicaments contenant ces composes | |
| IT1133086B (it) | Preparato medicinale per trattare carcinomi e procedimento per la sua produzione | |
| IL96161A0 (en) | Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency | |
| FR2326187A1 (fr) | Acyl cyanoguanidines utilisables comme medicaments | |
| FR2638638B1 (fr) | Pate adhesive pour la protection de la peau, son procede de preparation, ses applications therapeutiques et compositions pharmaceutiques la contenant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |
Country of ref document: DK |